Lucid-MS
- Generic Name
- Lucid-MS
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Huge Biopharma Australia Pty Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT06595706
- Locations
- 🇦🇺
Cmax Clinical Research, Adelaide, Maryland, Australia
Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- FSD Pharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05821387
- Locations
- 🇨🇦
Biopharma Services Incorporated, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath